Poolbeg Pharma - Key POLB 002 European Patent Granted
POLB Thu, 14 Apr 2022, 05:00pm BST
Jeremy Skillington, PhD, CEO of Poolbeg Pharma, discusses the continued expansion of the POLB 002 patent family following European Patent Office approval.
Jeremy Skillington
Chief Executive Officer
Management Team, Poolbeg Pharma
Wed, 3 Jan 2024, 11:00am GMT
Jeremy Skillington, Chief Executive Officer
Wed, 30 Nov 2022, 10:00am GMT
Jeremy Skillington, Chief Executive Officer
Mon, 5 Sep 2022, 11:00pm BST
Cathal Friel, Chairman
Wed, 27 Apr 2022, 12:00pm BST
Jeremy Skillington, Chief Executive Officer
Thu, 14 Apr 2022, 5:00pm BST
Jeremy Skillington, Chief Executive Officer
Fri, 1 Apr 2022, 7:05am BST
Jeremy Skillington, Chief Executive Officer
Fri, 25 Mar 2022, 7:05am GMT
Management Team, Poolbeg Pharma
Thu, 3 Mar 2022, 9:00am GMT
Liam Tremble, PhD, Project Manager
Thu, 24 Feb 2022, 7:05am GMT
Jeremy Skillington, Chief Executive Officer
Mon, 31 Jan 2022, 7:05am GMT
Cathal Friel, Chairman
Mon, 6 Dec 2021, 7:05am GMT
Elaine Sullivan, Poolbeg Scientific Advisory Board
Wed, 1 Dec 2021, 7:00am GMT
Cathal Friel, Chairman
Thu, 18 Nov 2021, 5:11pm GMT
Jeremy Skillington, Chief Executive Officer
Tue, 20 Jul 2021, 9:00am BST